News and publishing service for medical and biotechnology related companies
Contact us:
415.949.5050
twitter
facebook
linkedin
News and publishing service for medical and biotechnology related companies
Home
About
Clients
NewsRoom
Solutions
Events
Contact
Headlines
PaxMedica Inc. (PXMD) Completes Key Type-B FDA Meeting, Discussing Positive Results from PAX-HAT-301 Study
Study Shows Autistic People Have Lower Life Expectancy Than General Population
Topical Analgesics Emerge as Important Pain-Management Tools
Autoimmunity Patients Face Cost, Diagnosis, Care Challenges
SOHM Inc. (SHMN) Is ‘One to Watch’
BioMedNewsBreaks
BioMedNewsBreaks — Branded Legacy Inc. (BLEG) Retires 400M Common Shares, Announces Other Key Moves to Enhance Shareholder Value
Branded Legacy Inc. (BLEG)
December 7, 2023
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) CEO Featured in Just-Released Fireside Chat Video
Astiva Health
December 6, 2023
BioMedNewsBreaks — Astiva Health Partners with IBN to Deliver Corporate Communications, Increase Awareness
Astiva Health
December 6, 2023
BioMedNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Interim Analysis on Global Berubicin Trial Showing Promising Results
CNS Pharmaceuticals Inc. (CNSP)
December 6, 2023
BioMedNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Closes Non-Brokered Private Placement
FSD Pharma Inc. (HUGE)
December 5, 2023
View More BioMedNewsBreaks
BioMedWire Articles
The 2023 Nobel Prize in Chemistry’s Spotlight on Nanotechnology Shines Light on Clene Inc. (NASDAQ: CLNN) Efforts to Develop Catalytically Active Nanoparticles
Clene Inc. (CLNN)
December 8, 2023
Researchers Harnessing Immune System to Fight Cancer More Effectively
Renovaro BioSciences Inc. (RENB)
December 7, 2023
Four Niches e-Commerce Startups Can Leverage
NextPlat Corp. (NXPL)
December 6, 2023
PaxMedica Inc. (NASDAQ: PXMD) Completes Key Type-B FDA Meeting, Discussing Positive Results from PAX-HAT-301 Study
PaxMedica Inc. (PXMD)
December 6, 2023
Already-Approved Treatments Could Be Tested in Fight Against Brain Metastasis
CNS Pharmaceuticals Inc. (CNSP)
December 5, 2023
View All BioMedWire Articles
Public Press Releases
Filter Releases
Filters
Sector
Aerospace and Defense
Banking and Finance
Banking
Biotechnology
Internet
Media
Metal and Mineral
Chemicals
Computer
Consumer Goods
Pharmaceutical
Oil & Energy
Real Estate
Software
Energy
Entertainment
Food and Beverage
Healthcare
Telecommunications
Transportation
Utilities
Remove All Filters
Symbol
Release
Time
Source
{{ release.qmtopics.qmsymbol[0].symbol }}
{{ release.headline }}
{{ release.datetime | amDateFormat:'hh:mm A'}}
{{ release.source }}
Load More
Official NewsWire Relationships
BioMedWire Currently Accepts
Bitcoin
Bitcoin Cash
Ethereum
Litecoin
USD Coin
Contact us:
415.949.5050